Erythropoiesis stimulating agents: approaches to modulate activity.
about
Treatment Options for Primary Autoimmune Hemolytic Anemia: A Short Comprehensive ReviewErythropoietin and diabetes mellitusThe effect of erythropoiesis-stimulating agents in patients with therapy-refractory autoimmune hemolytic anemia.Half-life extended biotherapeutics.Hepcidin: Homeostasis and Diseases Related to Iron Metabolism.Neuroprotective effects of erythropoietin on neurodegenerative and ischemic brain diseases: the role of erythropoietin receptor.Neuroprotective effect of a new variant of Epo nonhematopoietic against oxidative stress.
P2860
Q26773178-44C2C1D8-30B9-4A70-8655-C0237968A086Q26777878-C667CFDD-C226-45BD-843F-BDE6ACC6CEA5Q38351622-65C87D59-19E4-434E-BB81-6B3649365EE2Q38770067-403C799B-5F87-48E6-B2B1-B63AEB54AF4CQ39313303-BE628BA4-0181-46CC-86C9-8D0DE1C5718CQ44689674-19641DA6-6E11-4AFB-B8A5-5BD403F73C46Q49505001-26CB0AFB-928A-4F86-850E-C1BBFC9BC496
P2860
Erythropoiesis stimulating agents: approaches to modulate activity.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Erythropoiesis stimulating agents: approaches to modulate activity.
@en
type
label
Erythropoiesis stimulating agents: approaches to modulate activity.
@en
prefLabel
Erythropoiesis stimulating agents: approaches to modulate activity.
@en
P2860
P356
P1476
Erythropoiesis stimulating agents: approaches to modulate activity.
@en
P2093
Angus M Sinclair
P2860
P304
P356
10.2147/BTT.S45971
P577
2013-07-03T00:00:00Z